ELP2

ELP2 is the WD40-repeat scaffold subunit of the Elongator complex, serving as a structural bridge between the Elp1 and Elp3 catalytic subunits to support tRNA wobble-base modification, histone H3 acetylation, and cytoskeletal association through microtubule binding (PMID:10777588, PMID:25960406). Its two seven-bladed β-propeller domains are essential for Elongator integrity, and structure-guided mutations that disrupt WD40 fold integrity abolish subunit interactions and complex activity (PMID:25960406). Biallelic ELP2 mutations cause a neurodevelopmental syndrome characterized by microcephaly, white matter loss, and neurodegeneration, driven by impaired tRNA modification and perturbed protein homeostasis (PMID:33976153). Outside Elongator, ELP2 (also called STIP) functions as a nuclear scaffold that assembles USP7–Mdm2 and USP7–p53 ternary complexes to regulate protein stability and interacts with STAT3 to modulate Hsp70 expression (PMID:26460617, PMID:22069317).

1. 2000 High

   Identifying ELP2 as a subunit of the Elongator complex established it as a WD40-repeat protein required for RNA Pol II-associated transcription elongation, with genetic epistasis proving all ELP subunits act in a single functional unit.

   Evidence Yeast Elongator complex purification, ELP2 deletion phenotyping, and genetic epistasis analysis with multiple ELP deletions

   PMID:10777588

   Open questions at the time

   • No structural information on how Elp2 contacts other Elongator subunits
   • Elongator's catalytic activities beyond transcription elongation were unknown
   • Metazoan relevance not established
2. 2007 Medium

   Demonstrating that the mammalian ELP2 ortholog (STIP) localizes to the nucleus, forms polymeric structures, and is essential for early embryonic viability across species established a conserved nuclear function beyond yeast transcription elongation.

   Evidence Deletion mutant mapping in mammalian cells, RNAi knockdown in C. elegans causing embryonic lethality, cross-species transgenic rescue with Drosophila and human genes

   PMID:17289020

   Open questions at the time

   • The molecular function of the rod-like polymers was not determined
   • Relationship to Elongator complex activity in metazoans was not addressed
3. 2011 Medium

   Showing that ELP2/STIP mediates STAT3-dependent Hsp70 induction revealed an Elongator-independent signaling role, linking ELP2 to stress-responsive gene activation in mammalian epithelial cells.

   Evidence siRNA knockdown, Hsp70 promoter-luciferase reporter, EMSA for STAT3 binding in cystic fibrosis epithelial cells

   PMID:22069317

   Open questions at the time

   • Whether ELP2–STAT3 interaction is direct or mediated through the Elongator complex was not resolved
   • Relevance to non-epithelial cell types not tested
4. 2015 High

   The crystal structure of Elp2 revealed a dual seven-bladed β-propeller architecture and showed that WD40 fold integrity is required for binding Elp1 and Elp3, for microtubule association, and for Elongator-dependent histone H3 acetylation, establishing Elp2 as the structural hub of the complex.

   Evidence X-ray crystallography of yeast Elp2, structure-guided mutagenesis, Co-IP/pulldown for Elp1/Elp3, microtubule co-sedimentation, in vivo histone H3 acetylation assays

   PMID:25960406

   Open questions at the time

   • Structural basis of microtubule binding at atomic resolution was not defined
   • How histone acetylation and tRNA modification activities are coordinated through Elp2 was unresolved
5. 2015 Medium

   Identification of ELP2/STIP as a nuclear scaffold assembling USP7–Mdm2 and USP7–p53 ternary complexes revealed a mechanism by which ELP2 modulates p53 pathway protein stability independent of Elongator.

   Evidence Reciprocal Co-IP, immunofluorescence co-localization, overexpression and knockdown effects on Mdm2 and p53 protein levels

   PMID:26460617

   Open questions at the time

   • Whether ELP2 binds USP7 directly or through intermediary proteins was not conclusively mapped
   • Physiological significance for tumorigenesis not tested in vivo
6. 2016 Low

   Demonstration that ELP2/STIP interacts with PP1γ and suppresses its phosphatase activity, leading to ERK1/2 hyper-activation, identified a phosphatase-regulatory mechanism for ELP2-mediated MAPK signaling.

   Evidence Co-IP, siRNA knockdown, phosphatase inhibitor rescue with Calyculin A, Western blot for p-ERK1/2

   PMID:27758712

   Open questions at the time

   • Single-lab finding with limited mechanistic depth; not independently confirmed
   • Direct binding between ELP2 and PP1γ not demonstrated with purified proteins
   • Relationship to Elongator complex function not addressed
7. 2021 High

   Mouse knock-in models of patient ELP2 mutations established that biallelic ELP2 loss-of-function causes impaired tRNA modification, perturbed protein homeostasis, defective neurogenesis, and white matter degeneration, defining a human neurodevelopmental disease mechanism.

   Evidence Mouse knock-in models, tRNA modification assays, brain MRI/tractography, neurogenesis and protein homeostasis analyses

   PMID:33976153

   Open questions at the time

   • Whether non-neuronal tissues are affected in patients was not systematically examined
   • Relative contributions of tRNA modification defects versus histone acetylation defects to pathology remain unresolved
8. 2023 Low

   Showing that ELP2 associates with STAT3 and NLRP3 to promote inflammasome activation and pyroptosis extended ELP2's signaling role to innate immune regulation, though the mechanistic basis remains preliminary.

   Evidence Co-IP, overexpression and siRNA knockdown, Western blot for NLRP3/GSDMD/GSDME in osteoblast-lineage cells treated with TNF-α

   PMID:37830762

   Open questions at the time

   • Reliance on computational docking without direct binding validation with purified proteins
   • Single-lab study in one cell type; generalizability unknown
   • Relationship between Elongator tRNA modification function and inflammasome activation not addressed

• How ELP2's Elongator-dependent functions (tRNA modification, histone acetylation) and Elongator-independent scaffolding functions (USP7–p53/Mdm2, STAT3, PP1γ) are coordinated or compartmentalized in cells remains unknown.
• No study has examined whether distinct ELP2 pools exist for Elongator versus non-Elongator functions
• No high-resolution structure of ELP2 in complex with USP7, STAT3, or PP1γ
• Tissue-specific contributions of ELP2's dual roles to neurodevelopmental disease pathology are undefined